MedPath

Northwestern University Human Resources

Northwestern University Human Resources logo
🇺🇸United States
Ownership
Private
Established
1851-01-28
Employees
5K
Market Cap
-
Website
https://www.venturecat.northwestern.edu

FDA Expands MenQuadfi Meningococcal Vaccine Approval to Include Infants as Young as 6 Weeks

The FDA approved an expanded indication for Sanofi's MenQuadfi meningococcal vaccine to include children aged 6 weeks to 23 months, making it the only MenACWY vaccine with no upper age limit.

Breakthrough Wireless Device Enables Remote Activation of Light-Sensitive Drugs for Pain Management

Scientists have developed the first wireless device capable of remotely activating photoactivable drugs, demonstrating effective pain management using photolabile morphine without typical opioid side effects.

Grove Biopharma Secures $30M Funding, Expands to New R&D Facility in Chicago's Fulton Market

Grove Biopharma, a Northwestern University spinout developing therapies for intracellular disease targets, has secured $30 million in Series A financing to fuel its expansion and research initiatives.

ALS Drug NU-9 Shows Promising Results for Alzheimer's Disease in Animal Study

Northwestern University researchers found that NU-9, an experimental drug approved for ALS clinical trials, effectively reduces toxic protein buildup in Alzheimer's disease animal models.

Sibel Health Secures $30 Million Series C Funding and New FDA Clearance for Interoperable Monitoring Platform

Sibel Health has closed a $30 million Series C financing round led by the Steele Foundation for Hope with significant participation from Dräger, positioning the company for commercial expansion.

SPARX3 Trial Investigates High-Intensity Exercise's Impact on Early-Stage Parkinson's Progression

Northwestern University researchers are conducting a Phase 3 clinical trial (SPARX3) to evaluate how different intensities of aerobic exercise affect disease progression in newly diagnosed, unmedicated Parkinson's patients.

FDA Clears Northwestern University's IND Application for Calidi's Novel Glioma Treatment CLD-101

The FDA has cleared Northwestern University's IND application for Calidi Biotherapeutics' CLD-101, a stem cell-based platform delivering oncolytic viruses for treating high-grade glioma, with Phase 1b/2 trials starting late 2024.

Strategies to Prevent Breast Cancer Development Under Investigation

Researchers are exploring vaccines to prime the immune system against malignant cells expressing MUC1, potentially preventing tumor formation in high-risk individuals.

Experts Highlight Advances in Lung Cancer Treatment: Immunotherapy, ADCs, and Equity in Care

Leading oncologists at the Chicago IVBM event discussed the transformation of lung cancer treatment, emphasizing the evolution of immunotherapy from second-line to first-line and early-stage treatments.

ASPC Congress 2024: AI, GLP-1s, and Novel Imaging Reshape Cardiovascular Disease Prevention

Leading cardiologists at ASPC Congress 2024 highlight the transformative role of AI and advanced imaging techniques in early detection of cardiovascular risks, particularly through coronary computed tomography angiography.

© Copyright 2025. All Rights Reserved by MedPath